Incyte (NASDAQ:INCY) Given Buy Rating at Truist Financial
Truist Financial reaffirmed their buy rating on shares of Incyte (NASDAQ:INCY – Free Report) in a research note released on Wednesday, Benzinga reports. They currently have a $91.00 price target on the biopharmaceutical company’s stock. Several other equities analysts have also recently issued reports on INCY. JMP Securities restated a market outperform rating and set […]
More Stories
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund (NYSEARCA:CORP) Stock Price Up 0.2% – Here’s What Happened
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund (NYSEARCA:CORP – Get Free Report)’s share price rose 0.2% on Wednesday ....
Vanguard Growth ETF Portfolio (TSE:VGRO) Trading 0.5% Higher – Should You Buy?
Vanguard Growth ETF Portfolio (TSE:VGRO – Get Free Report)’s stock price rose 0.5% during trading on Wednesday . The company...
Highest Performances (NASDAQ:PUYI) Shares Up 5.3% – Time to Buy?
Highest Performances Holdings Inc. (NASDAQ:PUYI – Get Free Report) was up 5.3% during mid-day trading on Wednesday . The stock...
First Niles Financial (OTCMKTS:FNFI) Shares Up 4.4% – Here’s What Happened
Shares of First Niles Financial, Inc. (OTCMKTS:FNFI – Get Free Report) shot up 4.4% during trading on Wednesday . The...
Geodrill (OTCMKTS:GDLLF) Stock Price Up 1.3% – What’s Next?
Geodrill Limited (OTCMKTS:GDLLF – Get Free Report)’s share price traded up 1.3% on Wednesday . The stock traded as high...
AllianzIM U.S. Large Cap Buffer20 Jan ETF (NYSEARCA:AZBJ) Trading Up 0.1% – Still a Buy?
AllianzIM U.S. Large Cap Buffer20 Jan ETF (NYSEARCA:AZBJ – Get Free Report) shares traded up 0.1% on Wednesday . The...